axicabtagene ciloleucel,tisagenlecleucel
daiichi sankyo,novartis,gilead
['axi-cel', 'tisa-cel']
#ash2022 | impress about the results from the spain cohort of patients that have received car t, what a difference between constructs 
Division of Hematology & Oncology | @MayoClinic Cancer Research and Cellular Therapy | I tweet on cancer, food and travel / non-medical advice.